Sentences with phrase «of epipen»

In an update posted Thursday, WPXI reported that Highmark agreed to cover the cost of the EpiPen.
A Pennsylvania man's dangerous allergic reaction to bee stings was bad enough without having to fight his insurance company to cover the cost of the EpiPen that saved his life.
Epinephrine (commonly found in the form of an EpiPen ® and better known as adrenaline, the «fight or flight» hormone) is «the principal blood - pressure raising hormone secreted by the adrenal medulla and is used medicinally especially as a heart stimulant.»
Now we know exactly how outrageous it is: The price of the EpiPen — an auto - injector of the inexpensive hormone ephinephrine — has skyrocketed by more than 600 % since 2008, Money reports, from around $ 100 for the standard two - pack in 2008 to more than $ 735 today.
Sales of the EpiPen, an epinephrine injection in the event of a life - threatening allergic reaction, rose 76 percent in one year recently.
At least two companies are seeking approval to sell a rival brand or generic version of EpiPen in the United States, but none are likely to be available until later next year.
Schneiderman in a statement said the review will focus on Mylan Pharmaceuticals Inc.'s decision to hike the cost of the the EpiPen, which generally sold for under $ 100 to nearly $ 600 as a potential violation of anti-competitive business laws.
After widespread outrage over the soaring price of the EpiPen, Attorney General Eric Schneiderman on Tuesday announced he had launched of an anti-trust investigation into the company that manufacturers the autoinjector.
For example, the insane jack up price of epipen and the contract is just tip of the iceberg.
Mylan stoked controversy this month after hiking the price of the EpiPen, commonly used to inject anti-allergens.
U.S. Sen. Chuck Schumer's Republican opponent is taking him to task for the contributions he's received from the chief executive officer of the company that boosted the price of the EpiPen.
Chicago Public Schools is simultaneously increasing its awareness of the dangers of severe allergies and stocking more of the EpiPen shots used to treat them this academic year.
The staff was great, and I was relieved that it's a nut - free zone so I didn't have to worry about Violet's allergies (we entered the world of EpiPen's this fall).
The interest intensified in 2016, when Mylan increased the cost of the EpiPen by 400 percent.
For instance, Ms. Bresch noted that Mylan had recently released a generic version of EpiPen.
In fact, the company says that since it came under attack in August, nearly 90 percent of EpiPen buyers have paid less than $ 100 per box because of insurance, discounts or coupons.
NEW YORK (AP)-- Saying she is «disappointed, saddened and deeply concerned» by the price hike of the EpiPen, actress Sarah Jessica Parker has cut ties with the company that makes the emergency allergy treatment.
This company reduced the out - of - pocket costs of EpiPen for some patients last week amid a wave of criticism from lawmakers and the public over the rapid escalation in the product's price in the past few years.
Pharmaceutical giant Mylan was embroiled in a controversy about its drug pricing last year when it hiked the price of EpiPen by more than 400 percent.
But the following year, in 2009, the wholesale acquisition price of EpiPen jumped 26 %; since 2012, prices have increased almost 30 % each year.
The «incorrect classification» of the EpiPen has financial consequences for the government, says CMS
In total, that amounts to a more than six-fold increase in the wholesale price of EpiPen since Mylan bought it.
Now, it should be noted that the potential generics options include Mylan's own «authorized generic» of the EpiPen, which is essentially the same device and medication minus the brand name (and available at half the price of the EpiPen).
Under Mylan, sales of EpiPen grew at an average annual rate of 33 %, more than doubling their 13 % annualized growth rate before Bresch took charge.
The price of the EpiPen has soared 500 % since generic drug company Mylan (myl) bought the treatment nine years ago.
Her comments came shortly after the Senate Committee on Aging asked Mylan to provide information on the reasoning behind what it called the «drastic» price increase of EpiPen, and the American Medical Association «urge [d]» Mylan to «rein in these exorbitant costs.»
Still, Mylan made no promises to lower the list price of EpiPen, or to refrain from future price hikes.
And on Thursday, Mylan expanded its discount program, offering up to $ 300 off the cost of EpiPen with the use of a special «savings card,» thereby reducing the price for patients paying out - of - pocket by half, the company said.
Shares of Mylan (myl) are trading at historically low valuations as the company's chief executive officer is set to face a congressional grilling on Wednesday over the price of its EpiPen emergency allergy treatment.
The top line cost of an EpiPen two - pack ballooned from about $ 100 to $ 608 over the past decade.
Mylan said last month that it would introduce the first generic version of EpiPen for $ 300, half the price of the branded product, as it tries to quell the backlash.
For example: Cigna's decision this week to drop coverage of the EpiPen in favor of a cheaper competitor and pharmacy benefits manager Express Scripts» original controversial decision to snub Gilead's hep C cure Sovaldi in favor of a competitor from AbbVie.
A test for the shares looms on Wednesday, when Mylan CEO Heather Bresch testifies before the U.S. House of Representatives Oversight Committee over price increases of EpiPen, an auto - injector of allergy medicine.
That's just one reason it's better for Mylan to offer a rebate instead of just slashing the price of EpiPen.
The generic pharmaceutical company came into the spotlight in August 2016 for raising the price of the EpiPen to $ 608.61 from $ 93.88 over the past decade.
According to filings, Coury made roughly $ 98 million in 2016, the same year in which the company faced criticism for the price of the EpiPen and the stock fell by almost 30 %, according to company filings.
Nor did Mylan pledge to refrain from raising the price of EpiPen further, something it has already been exploring since the product's main competitor Auvi - Q went off the market last year.
The generic drug company tripled the discount patients can receive on the cost of EpiPen to $ 300, up from the maximum $ 100 Mylan had previously offered with the use of its special «savings card.»
Besides, if Mylan were to actually reduce the price of EpiPen, it would have ramifications other than just lowering what individuals pay for the drug.
Rep. Jason Chaffetz, a Utah Republican, and Rep. Elijah Cummings, a Maryland Democrat, have sent the maker of the EpiPen a letter requesting additional documents clarifying the company's pricing structure.
Noting that the actual rebate should have been at least 10 percentage points higher, Wyden and Pallone said, «Today's letter is more evidence that while Mylan irresponsibly raised the price of EpiPen, they were also bilking taxpayers out of millions of dollars.»
Last year's scandal over Mylan's 500 % price hike of the EpiPen, a potentially lifesaving allergy treatment, tarnished Bresch's reputation, but it didn't hurt her business as much as some expected.
In conjunction with Mylan's SEC filing, a Mylan spokesperson stated that «the information provided to Congress has made clear that tax was part of the EpiPen Auto - Injector profitability analysis.»
Mylan came under fire in August when it raised the price of the EpiPen, a lifesaving allergy drug, to $ 608 for a two - pack.
That is, in part, because the price of EpiPen is tied to Mylan's stock performance, and Mylan's stock performance is tied to executive compensation.
Through all that, the price of an EpiPen has not been lowered one cent.
To make a somewhat long story short, when Mylan raised the price of the EpiPen, they went from a company quelling fear to a company instilling fear.
Meridian had to issue a recall of the EpiPen and EpiPen Jr. auto - injectors at the end of March as some of the devices, which are used for treating allergic reactions, had a defective part that potentially stopped them from working — an event that could be life - threatening.
We are very confident in the safety and efficacy of EpiPen products being produced at the site.»
«A list of Mylan's profits and expenses relating directly to the sale of EpiPens for each year from 2007 through 2015, including, but not limited to:»
a b c d e f g h i j k l m n o p q r s t u v w x y z